TABLE 2.

Two-sided probability values for all mortality data for 5- and 1-mg/kg daily doses of L-nystatin, L-amphotericin, ABLC, and amphotericin B for all experiments (except the pilot experiment) combined

Inferior regimen	P value for the following superior regimen:
	L-nystatina		L-amphotericin Ba		ABLCb		Amphotericin Ba
	5 mg/kg	1 mg/kgc	5 mg/kg	1 mg/kg	5 mg/kg	1 mg/kg	5 mg/kg	1 mg/kgc
L-nystatin, 1 mg/kgac	0.035		0.0004		0.024		0.56
L-amphotericin, 5 mg/kga	0.24
L-amphotericin, 1 mg/kga	<0.0001	0.032	0.005		0.017	0.49	0.002	0.072
ABLC, 5 mg/kgb	0.014		0.2				0.72
ABLC, 1 mg/kgb	<0.0001	0.15	0.0006		0.044		0.005	0.24
Amphotericin B, 5 mg/kga	0.008		0.23
Amphotericin B, 1 mg/kgac	0.03	0.95	0.0003		0.15		0.51
Liposomes and dextrose	<0.0001	<0.0001	<0.0001	<0.0001	<0.0001	<0.0001	<0.0001	<0.0001

^aGiven on days 1, 2, 4, and 7. 

^bSeven doses given on days 1 to 7. 

^cData are for only a single experiment.